Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

NCT00094809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer
Colorectal Cancer
Rectal Cancer

Interventions

DRUG: Placebo
DRUG: Pegfilgrastim

Sponsor

Amgen